对卵巢储备功能减退不孕女性行新鲜卵巢皮质组织活检、碎片化及自体移植
前瞻性临床队列研究纳入20例卵巢储备功能减退(DOR)不孕女性,随机选择一侧卵巢行4处活检、皮质组织碎片化后自体移植至腹膜囊袋,对侧卵巢为对照。术后10周可募集卵泡数在活检侧与对照侧无显著差异(1.0 vs 0.7,P=0.35),但12/20(60%)患者在1年随访内获得临床妊娠。
要点
- 卵巢活检联合碎片化皮质组织自体移植未增加术后10周可募集卵泡数。
- 仅3例患者在移植部位检测到4个卵泡生长,其中1枚MII卵子受精后胚胎发育失败。
- 12/20(60%)患者随访期间获得临床妊娠,每启动IVF/ICSI周期累积活产率18.4%。
核心结论
- 卵巢活检、碎片化及自体移植未增加DOR女性术后10周IVF/ICSI可募集卵泡数。
- 部分患者可能在术后5-8周出现卵泡反应。
- 作者认为未来可开展研究探讨活检本身的作用,并将IVF/ICSI刺激提前至第10周之前。
研究设计与样本
- 前瞻性临床队列研究,纳入2016年4月至2017年12月在丹麦Rigshospitalet生育门诊治疗的20例DOR女性。
- 患者随机选择左侧或右侧卵巢行腹腔镜下4处活检,皮质组织碎片化至约1 mm³后自体移植至腹膜囊袋,对侧卵巢为对照。
- 非妊娠患者平均随访280天(范围118-408天),妊娠者随访至分娩,非妊娠患者随访于2018年9月结束。
主要发现
- 术后10周卵巢刺激后成熟卵泡数活检侧 vs 对照侧为1.0 vs 0.7个(P=0.35)。
- 仅3例患者在术后24-268天于移植部位检测到4个卵泡生长,其中1枚MII卵子受精后胚胎发育失败。
- 总体AMH水平术后无显著变化(P=0.2);AFC每周增加0.14(95%CI 0.06;0.21,P<0.005),活检侧卵巢平均比对照侧少0.6个卵泡(95%CI 0.3;-0.88,P=0.01)。
- 术后1周雄烯二酮和睾酮分别显著升高0.63 nmol/L(95%CI 0.21;1.04)和0.11 nmol/L(95%CI 0.01;0.21),睾酮在10周内每周递增0.0095 nmol/L(95%CI 0.0002;0.0188,P=0.045)。
- 7/20例患者术后5-8周出现血清AMH升高,该组平均AMH从第1-4周的2.08 pmol/L(范围1.74-2.34)升至第5-8周的3.94 pmol/L(范围3.66-4.29)。
临床怎么用
- 当前研究未表明活检、碎片化及自体移植能增加术后10周IVF/ICSI可募集卵泡数。
- 作者认为未来可开展研究探讨活检本身的作用,并将IVF/ICSI刺激提前至第10周之前。
局限性
- 纳入患者数量有限。
- 缺乏未手术对照组。
- 20例中9例入组时无男性伴侣并接受供精治疗,但每例入组前平均已有6.8次(范围4-9)供精医学辅助生殖治疗失败。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can ovarian biopsying per se and/or autotransplantation of fragmented ovarian cortical tissue activate dormant follicles and increase the number of recruitable follicles for IVF/ICSI in women with diminished ovarian reserve (DOR)? SUMMARY ANSWER: Ovarian biopsying followed by immediate autotransplantation of fragmented cortical tissue failed to increase the number of recruitable follicles for IVF/ICSI 10 weeks after the procedure either at the graft site or in the biopsied ovary, but 12 of the 20 women subsequently had a clinical pregnancy during the 1-year follow-up. WHAT IS KNOWN ALREADY: Infertile women with DOR constitute a group of patients with poor reproductive outcome mainly due to the low number of mature oocytes available for IVF/ICSI. Recent studies have shown that in vitro activation of residual dormant follicles by both chemical treatment and tissue fragmentation has resulted in return of menstrual cycles and pregnancies in a fraction of amenorrhoeic women with premature ovarian insufficiency. STUDY DESIGN, SIZE, DURATION: This is a prospective clinical cohort study including 20 women with DOR treated at the fertility clinic, Rigshospitalet, Denmark, during April 2016-December 2017. Non-pregnant patients were on average followed for 280 days (range 118-408), while women who conceived were followed until delivery. Study follow-up of non-pregnant patients ended in September 2018. PARTICIPANTS, MATERIALS, SETTING, METHODS: The study included infertile women aged 30-39 years with preserved menstrual cycles, indication for IVF/ICSI and repeated serum measurements of anti-Müllerian hormone (AMH) ≤ 5 pmol/L. Patients were randomized to have four biopsies taken from either the left or the right ovary by laparoscopy followed by fragmentation of the cortical tissue to an approximate size of 1 mm3 and autotransplanted to a peritoneal pocket. The other ovary served as a control. Patients were followed weekly for 10 weeks with recording of hormone profile, antral follicle count (AFC), ovarian volume and assessment for ectopic follicle growth. After 10 weeks, an IVF/ICSI-cycle with maximal ovarian stimulation was initiated. MAIN RESULTS AND THE ROLE OF CHANCE: No difference in the number of mature follicles after ovarian stimulation 10 weeks after the procedure in the biopsied versus the control ovaries was observed (1.0 vs. 0.7 follicles, P = 0.35). In only three patients, growth of four follicles was detected at the graft site 24-268 days after the procedure. From one of these follicles, a metaphase II (MII) oocyte was retrieved and fertilized, but embryonic development failed. Overall AMH levels did not change significantly after the procedure (P = 0.2). The AFC increased by 0.14 (95% CI: 0.06;0.21) per week (P < 0.005), and the biopsied ovary had on average 0.6 (95% CI: 0.3;-0.88) follicles fewer than the control ovary (P = 0.01). Serum levels of androstenedione and testosterone increased significantly by 0.63 nmol/L (95% CI: 0.21;1.04) and 0.11 nmol/L (95% CI: 0.01;0.21) 1 week after the procedure, respectively, and testosterone increased consecutively over the 10 weeks by 0.0095 nmol/L (95% CI: 0.0002;0.0188) per week (P = 0.045). In 7 of the 20 patients, there was a serum AMH elevation 5 to 8 weeks after the procedure. In this group, mean AMH increased from 2.08 pmol/L (range 1.74-2.34) to 3.94 pmol/L (range 3.66-4.29) from Weeks 1-4 to Weeks 5-8. A clinical pregnancy was obtained in 12 of the 20 (60%) patients with and without medically assisted reproduction (MAR) treatments. We report a cumulated live birth rate per started IVF/ICSI cycle of 18.4%. LIMITATIONS, REASON FOR CAUTION: Limitations of the study were the number of patients included and the lack of a non-operated control group. Moreover, 9 of the 20 women had no male partner at inclusion and were treated with donor sperm, but each of these women had an average of 6.8 (range 4-9) unsuccessful MAR treatments with donor sperm prior to inclusion. WIDER IMPLICATIONS OF THE FINDINGS: Although 12 out of 20 patients became pregnant during the follow-up period, the current study does not indicate that biopsying, fragmenting and autotransplanting of ovarian cortical tissue increase the number of recruitable follicles for IVF/ICSI after 10 weeks. However, a proportion of the patients may have a follicular response in Weeks 5-8 after the procedure. It could therefore be relevant to perform a future study on the possible effects of biopsying per se that includes stimulation for IVF/ICSI earlier than week 10. STUDY FUNDING/COMPETING INTEREST(S): This study is part of the ReproUnion collaborative study, co-financed by the European Union, Interreg V ÖKS. The funders had no role in the study design, data collection and interpretation, or decision to submit the work for publication. None of the authors have a conflict of interest. TRIAL REGISTRATION NUMBER: NCT02792569.
引用
- Lunding SA, Pors SE, Kristensen SG, et al. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve. Hum Reprod. 2019. PMID: 31593582. doi:10.1093/humrep/dez152
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。